386 results on '"Vigneault E"'
Search Results
2. Infection after prostatic transrectal fiducial marker implantation for image guided radiation therapy
3. Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
4. Incidence of cardiovascular death in localized prostate cancer and its relationship to androgen blockade: Long-term data from two phase III trials
5. A randomized Phase 3 trial of Metformin in patients initiating androgen deprivation therapy as PRevention and Intervention of MEtabolic syndrome: The PRIME Study
6. Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2 Gy) vs. Standard Dose (70.2 Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer
7. Biochemical Failure in Intermediate Risk Prostate Cancer: Then What? Long-Term Data from a Phase III Trial
8. Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786)
9. Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data
10. PD-0497 Initial results for a state of the art “transferless” multi-modality imaging brachytherapy suite
11. Prospective Phase II Trial of Once-weekly Hypofractionated Radiation Therapy for Low-risk Adenocarcinoma of the Prostate: Late Toxicities and Outcomes
12. Ultra-Hypo Fractionated Prostate IGRT with HDR Brachytherapy Boost as Compared to a Moderate-Hypo Fractionated Approach: Patient Reported Outcomes (PRO's) of a Phase Two Study Interim Analysis
13. Combined Risk Factors and Outcomes in High-Risk Prostate Cancer: Secondary Analysis of a Phase III Trial
14. Cardiovascular Causes of Death in Patients Treated for Localized Prostate Cancer
15. Salvage Prostate Brachytherapy in Radiorecurrent Prostate Cancer: An International Delphi Consensus Study
16. A Pilot Study of Salvage HDR Brachytherapy in Recurrent Prostate Cancer: 5 Year Toxicity and Outcomes
17. A0601 - Incidence of cardiovascular death in localized prostate cancer and its relationship to androgen blockade: Long-term data from two phase III trials
18. A Randomized Phase II Trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) Brachytherapy as Monotherapy in Localized Prostate Cancer: Analysis of Initial Arms of Canadian Cancer Trials Group PR19 (NCT02960087).
19. Évolution clinique des patients atteints d’un cancer prostatique de risque intermédiaire traités par implants permanents d’iode-125 : l’expérience de l’Hôtel-Dieu de Québec
20. Ultra-Hypofractionated (UHF) Compared to Moderate-Hypofractionated (MHF) Prostate IGRT With HDR Brachytherapy Boost (BB): Four-Year Toxicities and Local Control
21. Primary Endpoint Analysis of a Randomized Phase III Trial of Hypofractionated vs. Conventional Post-Prostatectomy Radiotherapy: NRG Oncology GU003
22. OC-0044 Clinical evaluation of an interactive multi-criteria optimisation workflow for HDR brachytherapy
23. PO-1320 Infectious Risk After Prostatic Transrectal Fiducial Marker Implantation in Radiation Therapy
24. P024 - A randomized Phase 3 trial of Metformin in patients initiating androgen deprivation therapy as PRevention and Intervention of MEtabolic syndrome: The PRIME Study
25. OC-0106 US-guided EM tracked system compared to OncentraProstate for HDR brachytherapy: a first in-men study
26. OC-0101 17 years' of EBRT plus HDR brachytherapy boost in high risk localized prostate cancer patients
27. PO-0209 Practical considerations on the use of EM tracking technology for clinical HDR brachytherapy
28. PP-0156 HDR and LDR comparison as monotherapy in localized prostate cancer: PSA kinetic and late toxicity
29. Le rôle de la curiethérapie prostatique guidée par imagerie 3D sur le ratio thérapeutique : l'expérience du CHU de Québec
30. PO-2169 Systematic MC dose recalculation pipeline: a use case in permanent implant prostate brachytherapy
31. Salvage Low Dose Rate Prostate Brachytherapy: Clinical Outcomes of a Phase II Trial for Local Recurrence after External Beam Radiotherapy (NRG/RTOG -0526)
32. Analysis of PSA Kinetics and Late Treatment Related Toxicity in a Phase 2 Randomized Pilot Study Comparing High Dose Rate Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
33. OC-1030: Salvage LDR Prostate Brachytherapy: Results of NRG/RTOG-0526 Trial for Local Recurrence after EBRT
34. Guideline for testosterone recovery in localized prostate cancer treated with different ADT duration: Long-term data from two prospective randomized trials
35. Daily Online Prostate Targeting: an evaluation of the error chain, optimal margins and clinical workload
36. Robustness and precision of an automatic marker detection algorithm for online prostate daily targeting using a standard V-EPID
37. PD-0579 Ultra-hypo compared to moderate-hypo fractionated prostate IGRT with HDR brachytherapy boost.
38. IMAGE-Guided Brachytherapy for Primary Vaginal Cancers
39. Long-Term Results of NRG Oncology/RTOG 0321 A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiotherapy for Adenocarcinoma of the Prostate
40. Outcomes Based on Risk Factors in Intermediate Risk Prostate Cancer: a Secondary Analysis of a Randomized Phase III Trial
41. The Advantages of Trus-Based HDR Prostate Treatment When Compared to CT Planning
42. ULTRA-HYPO (UHF) Compared to Moderate-HYPO (MHF) Fractionated Prostate IGRT with HDR Brachytherapy BOOST: LONG TERM Toxicity, Acceptability and Efficiency of Delivery
43. Employment Outcomes for Recent Canadian Radiation Oncology Graduates
44. OC-0400 Are prostate contours affected by the RO's clinical experience in prostate HDR brachytherapy?
45. OC-0159 Long-Term Results of RTOG 0321: HDR Brachytherapy and External Beam Radiotherapy for Prostate Cancer
46. Short Term Androgen Deprivation Therapy Without or With Pelvic Lymph Node Treatment Added to Prostate Bed Only Salvage Radiotherapy: The NRG Oncology/RTOG 0534 SPPORT Trial
47. A Phase II Randomized Pilot Study Comparing High-Dose Rate Brachytherapy and Low-Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
48. 110 - Guideline for testosterone recovery in localized prostate cancer treated with different ADT duration: Long-term data from two prospective randomized trials
49. Contouring and Target Variability in Vaginal Tumors Treated with MR-Based Interstitial Brachytherapy: A Multi-institutional Contouring Study
50. Significance of Testosterone Suppression in Localized Prostate Cancer Treated with Androgen Deprivation Therapy and Radiotherapy: Data from 2 Phase 3 Trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.